This inventor holds 1 USPTO granted patent. Top assignee: Macau University of Science and Technology. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations in Cancer Treatment by Inventor Wen-Luan Hsiao
Introduction
Wen-Luan Hsiao, an esteemed inventor located in Macau, China, is recognized for his significant contributions to the medical field, particularly in cancer treatment. With a focus on innovative methods, he has developed a groundbreaking patent that offers new hope for patients suffering from non-small cell lung cancer.
Latest Patents
Hsiao holds a vital patent titled "Method of Treating Cancer." This patent outlines a method for treating cancer, specifically targeting non-small cell lung cancer, through the administration of mitoxantrone. Furthermore, the invention also discloses a method for inhibiting ROS1 kinase, reinforcing the compound's potential in cancer therapy. Additionally, a pharmaceutical composition comprising mitoxantrone is included in the patent, showcasing a significant advancement in cancer treatment options.
Career Highlights
Wen-Luan Hsiao is affiliated with the Macau University of Science and Technology, where he applies his research and expertise to further advancements in medical science. His dedication to developing innovative treatments is evident in his work on cancer therapies, which continues to impact the field.
Collaborations
Throughout his career, Hsiao has collaborated with distinguished colleagues, including Xiao-Jun Yao and Lai-Han Elaine Leung. These collaborations have fostered a creative environment that encourages the pursuit of innovative solutions in cancer research and treatment.
Conclusion
Wen-Luan Hsiao exemplifies the spirit of innovation in the medical field. His patent for a method of treating cancer has the potential to significantly alter the landscape of cancer therapies, offering new hope to patients and inspiring ongoing research in this critical area of health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile